FR3064180B1 - Formulations comprenant des actifs issus de la plante murraya koenigii - Google Patents
Formulations comprenant des actifs issus de la plante murraya koenigii Download PDFInfo
- Publication number
- FR3064180B1 FR3064180B1 FR1852453A FR1852453A FR3064180B1 FR 3064180 B1 FR3064180 B1 FR 3064180B1 FR 1852453 A FR1852453 A FR 1852453A FR 1852453 A FR1852453 A FR 1852453A FR 3064180 B1 FR3064180 B1 FR 3064180B1
- Authority
- FR
- France
- Prior art keywords
- formulations
- plant
- murraya koenigii
- koenigii
- active ingredients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000002393 Murraya koenigii Species 0.000 title abstract 5
- 239000004480 active ingredient Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000008734 Bergera koenigii Nutrition 0.000 abstract 3
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 abstract 3
- 229960003105 metformin Drugs 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 241000196324 Embryophyta Species 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000011002 quantification Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
[0001] Formulations pour l'administration par voie orale ou formulations pour application sur peau saine ou lésée comprenant des actifs issus de la plante Murray a koenigii. Composition comprenant au moins un actif issu de la plante Murraya koenigii, ledit actif étant la metformine. [0002] Identification et quantification de la metformine dans Murraya koenigii et attribution de l'activité de Murraya koenigii dans le traitement du syndrome métabolique et des troubles cognitifs à la présence en faible dose de metformine dans Murraya koenigii.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762474253P | 2017-03-21 | 2017-03-21 | |
USUS62474253 | 2017-03-21 | ||
US201862637200P | 2018-03-01 | 2018-03-01 | |
USUS62637200 | 2018-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3064180A1 FR3064180A1 (fr) | 2018-09-28 |
FR3064180B1 true FR3064180B1 (fr) | 2023-04-21 |
Family
ID=61911534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1852453A Active FR3064180B1 (fr) | 2017-03-21 | 2018-03-21 | Formulations comprenant des actifs issus de la plante murraya koenigii |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3064180B1 (fr) |
WO (1) | WO2018172436A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020246976A1 (fr) * | 2019-06-06 | 2020-12-10 | Muhammed Majeed | Composition pour l'inhibition de transporteur de prostaglandines et applications thérapeutiques associées |
FR3106755B1 (fr) * | 2020-02-03 | 2022-07-15 | Gattefosse Sas | Extrait de murraya koenigii et son utilisation en cosmetique |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009066303A2 (fr) * | 2007-11-22 | 2009-05-28 | Ganga Raju Gokaraju | Nouvelle composition phytochimique synergique pour le traitement de l'obésité |
-
2018
- 2018-03-21 FR FR1852453A patent/FR3064180B1/fr active Active
- 2018-03-21 WO PCT/EP2018/057220 patent/WO2018172436A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
FR3064180A1 (fr) | 2018-09-28 |
WO2018172436A1 (fr) | 2018-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2010123052A (ru) | Авенантрамидсодержащие композиции | |
NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
ATE339187T1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
MA38576B2 (fr) | Formulations de colchicine à libération prolongée et procédés d'utilisation de ces dernières | |
MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
ECSP045029A (es) | Composiciones de valdecoxib de disgregación intraoral | |
FR3064180B1 (fr) | Formulations comprenant des actifs issus de la plante murraya koenigii | |
RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
WO2022175746A8 (fr) | Inhibiteurs de tyk2 et leurs utilisations | |
RU2009131745A (ru) | Лекарственное средство для профилактического и/или терапевтического лечения деменции по типу альцгеймера | |
ATE384529T1 (de) | Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen | |
MX2021000714A (es) | Preparacion medicinal para uso externo. | |
JPWO2014163030A1 (ja) | 馬の炎症治療のための製剤 | |
FR2967576B1 (fr) | Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament | |
HRP20230735T1 (hr) | Betahistin, ili njegova farmaceutski prihvatljiva sol, i inhibitor monoamin oksidaze, za uporabu u liječenju ili prevenciji jednog ili više simptoma vrtoglavice kod subjekta | |
CR20230192A (es) | Formulación sólida | |
JP5740062B1 (ja) | 毛状疣贅病の予防および/または治療方法 | |
HRP20211661T1 (hr) | Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti | |
Sethi et al. | The role of curcumin in modern medicine | |
AR122228A1 (es) | Composiciones de spray nasal antiviral y viricida y métodos de tratamiento relacionados | |
RU2008152691A (ru) | Способ профилактики и лечения мастита у коров | |
CN114040756A (zh) | 疾病控制方法 | |
MA41102A (fr) | Compositions contenant de la curcumine à biodisponibilité améliorée | |
DK93091D0 (da) | Laegemidler til behandling af toxoplasmose | |
WO2019244014A3 (fr) | Nouvelle utilisation d'inhibiteurs de monoamine oxydase de type b |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20220819 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |